148 related articles for article (PubMed ID: 25768400)
1. Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting.
Xiong J; Bian J; Wang L; Zhou JY; Wang Y; Zhao Y; Wu LL; Hu JJ; Li B; Chen SJ; Yan C; Zhao WL
Blood Cancer J; 2015 Mar; 5(3):287. PubMed ID: 25768400
[TBL] [Abstract][Full Text] [Related]
2. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.
Arlauckas SP; Kumar M; Popov AV; Poptani H; Delikatny EJ
Oncotarget; 2017 Mar; 8(10):16518-16530. PubMed ID: 28157707
[TBL] [Abstract][Full Text] [Related]
3. EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
Mariotto E; Bortolozzi R; Volpin I; Carta D; Serafin V; Accordi B; Basso G; Navarro PL; López-Cara LC; Viola G
Biochem Pharmacol; 2018 Sep; 155():213-223. PubMed ID: 30006194
[TBL] [Abstract][Full Text] [Related]
4. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
Zech SG; Kohlmann A; Zhou T; Li F; Squillace RM; Parillon LE; Greenfield MT; Miller DP; Qi J; Thomas RM; Wang Y; Xu Y; Miret JJ; Shakespeare WC; Zhu X; Dalgarno DC
J Med Chem; 2016 Jan; 59(2):671-86. PubMed ID: 26700752
[TBL] [Abstract][Full Text] [Related]
5. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
Arlauckas SP; Popov AV; Delikatny EJ
Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
[TBL] [Abstract][Full Text] [Related]
6. Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.
Ramírez de Molina A; Gallego-Ortega D; Sarmentero-Estrada J; Lagares D; Gómez Del Pulgar T; Bandrés E; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2008; 40(9):1753-63. PubMed ID: 18296102
[TBL] [Abstract][Full Text] [Related]
7. Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
Lacal JC; Campos JM
Mol Cancer Ther; 2015 Jan; 14(1):31-9. PubMed ID: 25487918
[TBL] [Abstract][Full Text] [Related]
8. A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.
Falcon SC; Hudson CS; Huang Y; Mortimore M; Golec JM; Charlton PA; Weber P; Sundaram H
Oncogenesis; 2013; 2(3):e38. PubMed ID: 25522435
[TBL] [Abstract][Full Text] [Related]
9. Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells.
Sola-Leyva A; López-Cara LC; Ríos-Marco P; Ríos A; Marco C; Carrasco-Jiménez MP
Sci Rep; 2019 Mar; 9(1):5109. PubMed ID: 30911014
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Unique Inhibitor-Binding Site on Choline Kinase α.
Kall SL; Delikatny EJ; Lavie A
Biochemistry; 2018 Feb; 57(8):1316-1325. PubMed ID: 29389115
[TBL] [Abstract][Full Text] [Related]
11. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.
Ramírez de Molina A; Sarmentero-Estrada J; Belda-Iniesta C; Tarón M; Ramírez de Molina V; Cejas P; Skrzypski M; Gallego-Ortega D; de Castro J; Casado E; García-Cabezas MA; Sánchez JJ; Nistal M; Rosell R; González-Barón M; Lacal JC
Lancet Oncol; 2007 Oct; 8(10):889-97. PubMed ID: 17851129
[TBL] [Abstract][Full Text] [Related]
12. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
13. Choline kinase alpha depletion selectively kills tumoral cells.
Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
[TBL] [Abstract][Full Text] [Related]
14. A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas.
Hernando E; Sarmentero-Estrada J; Koppie T; Belda-Iniesta C; Ramírez de Molina V; Cejas P; Ozu C; Le C; Sánchez JJ; González-Barón M; Koutcher J; Cordón-Cardó C; Bochner BH; Lacal JC; Ramírez de Molina A
Oncogene; 2009 Jul; 28(26):2425-35. PubMed ID: 19448670
[TBL] [Abstract][Full Text] [Related]
15. Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.
Granata A; Nicoletti R; Perego P; Iorio E; Krishnamachary B; Benigni F; Ricci A; Podo F; Bhujwalla ZM; Canevari S; Bagnoli M; Mezzanzanica D
Oncotarget; 2015 May; 6(13):11216-30. PubMed ID: 25796169
[TBL] [Abstract][Full Text] [Related]
16. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.
Ramírez de Molina A; Penalva V; Lucas L; Lacal JC
Oncogene; 2002 Jan; 21(6):937-46. PubMed ID: 11840339
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and mechanistic characterisation of Choline Kinase-α.
Hudson CS; Knegtel RM; Brown K; Charlton PA; Pollard JR
Biochim Biophys Acta; 2013 Jun; 1834(6):1107-16. PubMed ID: 23416529
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
[TBL] [Abstract][Full Text] [Related]
19. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
[TBL] [Abstract][Full Text] [Related]
20. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
Zhang QL; Wang L; Zhang YW; Jiang XX; Yang F; Wu WL; Janin A; Chen Z; Shen ZX; Chen SJ; Zhao WL
Leukemia; 2009 Aug; 23(8):1507-14. PubMed ID: 19282831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
